Ovarian cancer tumor infiltrating T-regulatory (Treg) cells are associated with a metastatic phenotype

Gynecologic Oncology

Volumn 116, Issue 3, 2010, Pages 556-562

  Barnett, Jason C ^a   Bean, Sarah M ^a   Whitaker, Regina S ^a   Kondoh, Eiji ^a,b   Baba, Tsukasa ^a,b   Fujii, Shingo ^b   Marks, Jeffrey R ^a   Dressman, Holly K ^c   Murphy, Susan K ^a,c   Berchuck, Andrew ^a,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b KYOTO UNIVERSITY   (Japan)

^c DUKE UNIVERSITY   (United States)

Author keywords

Ovarian cancer; Tumor infiltrating lymphocytes

Indexed keywords

CD8 ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ACCURACY; ADULT; ADVANCED CANCER; AGED; ANALYSIS OF VARIANCE; ANTIGEN PRESENTATION; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CD8+ T LYMPHOCYTE; COMPUTER PROGRAM; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE EXPRESSION; GENOMICS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; METASTASIS; MICROARRAY ANALYSIS; OVARY CANCER; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGEN PRESENTATION; FEMALE; GENE EXPRESSION; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MIDDLE AGED; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; PHENOTYPE; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 75749125293     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.11.020     Document Type: Article

References (24)

1. Zou W.P. Immunosuppressive networks in the tumor environment and their therapeutic relevance. Nat. Rev., Cancer 5 (2005) 263-274
2. Heintz A.P., Odicino F., Maisonneuve P., et al. Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int. J. Gynaecol. Obstet. 95 (2006) S161-S192
3. Zhang L., Conejo-Garcia J.R., Katsaros D., et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N. Engl. J. Med. 348 (2003) 203-213
4. Curiel T.J., Coukos G., Zou L., et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10 (2004) 942-949
5. Sato E., Olson S.H., Ahn J., et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 18538-18543
6. Leffers N., Gooden M.m., and de Jong R.A. Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer. Cancer Immunol. Immunother. 58 (2009) 449-459
7. Wolf D., Wolf A.M., Rumpold H., et al. The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin. Cancer Res. 11 (2005) 8326-8331
8. Bignone P.A., and Banham A.H. FOXP3+ regulatory T cells as biomarkers in human malignancies. Expert Opin. Biol. Ther. 8 (2008) 1897-1920
9. Nelson B.H. The impact of T-cell immunity on ovarian cancer outcomes. Immunol. Rev. 222 (2008) 101-116
10. Berchuck A., Iversen E.S., Luo J., et al. Microarray analysis of early stage serous ovarian cancers demonstrates profiles predictive of favorable outcome. Clin. Cancer Res. 15 (2009) 2448-2455
11. Berchuck A., Iversen E.S., Lancaster J.M., et al. Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Clin. Cancer Res. 15 (2005) 3686-3696
12. West M., Blanchette C., Dressman H., et al. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 11462-11467
13. Shah C.A., Allison K.H., Garcia R.L., Gray H., Goff B.A., and Swisher E.M. Intratumoral T cells, tumor-associated macrophages, and regulatory T-cells: Association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer. Gynecol. Oncol. 109 (2008) 215-219
14. Salama P., Phillips M., Grieu F., et al. Tumor-infiltrating FOXP3 T regulatory cells show strong prognostic significance in colorectal cancer. J. Clin. Oncol. 27 (2009) 186-192
15. Ping Y., Lee Y., Liu W., et al. Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J. Exp. Med. 2015 (2005) 779-791
16. Li X., Ye F., Chen H., Lu W., Wan X., and Xie X. Human ovarian carcinoma cells generate CD4+CD25+ regulatory T cells from peripheral CD4+CD25- T cells through secreting TGF-B. Cancer Lett. 253 (2007) 144-153
17. Wei S., Kryczek I., Edwards R.P., et al. Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma. Cancer Res. 67 (2007) 7487-7494
18. Nesbeth Y., Scarlett U., Cubillos-Ruiz J., et al. CCL5-Mediated endogenous antitumor immunity elicited by adoptively transferred lymphocytes and dendritic cell depletion. Cancer Res. 69 (2009) 6331-6338
19. Dufour J.H., Dziejman M., Liu M.T., et al. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 168 7 (2002) 3195-3204
20. Tothill R.W., Tinker A.V., George J., et al. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin. Cancer Res. 14 (2008) 5198-5208
21. Weinberg R.A. Crowd control: tumor immunology and immunotherapy. The Biology of Cancer. Garland Science (2007), Taylor and Francis Group, LLC
22. Kronin V., Wu L., Gong S., et al. DEC-205 as a marker of dendritic cells with regulatory effects on CD8 T cell responses. Int. Immunol. 12 5 (2000) 731-735
23. Xystrakis E., Dejean A.S., Bernard I., et al. Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation. Blood 104 10 (2004) 3294-3301
24. Nair S., Boczkowski D., Fassnacht M., Pisestky D., and Gilboa E. Vaccination against the Forkhead family transcription factor Foxp3 enhances tumor immunity. Cancer Res. 67 (2007) 371-380